https://www.selleckchem.com/products/ikk-16.html
s associated with unfavorable treatment outcomes overall and among HIV-seronegative patients (HR= 1.16 (95% CI = [1.05;1.27]). Increased neutrophil count prior to anti-TB treatment initiation was associated with unfavorable treatment outcomes, particularly among HIV-seronegative patients. Further prospective studies evaluating neutrophil count in response to drug treatment and association with TB treatment outcomes are warranted. Increased neutrophil count prior to anti-TB treatment initiation was associated with unfavorable treatment ou
Like
Comment
Share
